Energy expenditure, physical activity, and body composition of ambulatory adults with hereditary neuromuscular disease

American Journal of Clinical Nutrition

Volumn 67, Issue 6, 1998, Pages 1162-1169

  McCrory, Megan A ^a   Kim, Hie Ran ^b   Wright, Nancy C ^b   Lovelady, Cheryl A ^b   Aitkens, Susan ^b   Kilmer, David D ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

Body composition; Disability; Energy cost; Energy expenditure; Fat free mass; Humans; Neuromuscular disease; Physical activity

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; BODY COMPOSITION; CALORIMETRY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROMUSCULAR DISEASE; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0031862877     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.6.1162     Document Type: Article

References (44)

1. World Health Organization. International classification of impairments, disabilities, handicaps. Geneva: World Health Organization, 1980.
2. Pearson AM, Young RB. Diseases and disorders of muscle. Adv Food Nutr Res 1993;37:341-423.
3. Carter GT, Abresch RT, Fowler WM Jr, Johnson ER, Kilmer DD, McDonald CM. Hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil 1995;74(suppl):S140-9.
4. Fowler WM, Abresch RT, Aitkens S, et al. Profiles of neuromuscular diseases: design of the protocol. Am J Phys Med Rehabil 1995;74(suppl):S62-9.
5. Johnson ER, Abresch RT, Carter GT, et al. Myotonic dystrophy. Am J Phys Med Rehabil 1995;74(suppl):S 104-16.
6. Kilmer DD, Abresch RT, McCrory MA, et al. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 1995;74(suppl):S131-9.
7. McDonald CM, Johnson ER, Abresch RT, Carter GT, Fowler WM Jr, Kilmer DD. Limb-girdle syndromes. Am J Phys Med Rehabil 1995;74(suppl):S117-30.
8. Florence JM, Brooke MH, Hagberg JM, Carroll E. Endurance exercise in neuromuscular disease. In: Serratrice G, ed. Neuromuscular diseases. New York: Raven Press, 1984:577-81.
9. Carroll JE, Hagberg JM, Brooke MH, Shumate JB. Bicycle ergometry and gas exchange measurements in neuromuscular diseases. Arch Neurol 1979;36:457-61.
10. Rimmer JH, Braddock D, Pitetti KH. Research on physical activity and disability: an emerging national priority. Med Sci Sports Exerc 1996;28:1366-72.
11. US Department of Health and Human Services. Physical activity and health: a report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.
12. Kanda F, Fuji Y, Takahashi K, Fujita T. Dual-energy X-ray absorptiometry in neuromuscular diseases. Muscle Nerve 1994;17:431-5.
13. Edmonds CJ, Smith T, Griffiths RD, Mackenzie J, Edwards RHT. Total body potassium and water, and exchangeable sodium, in muscular dystrophy. Clin Sci 1985;68:379-85.
14. Björntorp P, Schröder G, Orndahl G. Carbohydrate and lipid metabolism in relation to body composition in myotonic dystrophy. Diabetes 1973;22:238-42.
15. Delwaide PA, Delwaide PJ, Penders CA. Isotope studies of body composition in neuromuscular disease. J Neurol Sci 1972;15:339-49.
16. Ravussin E, Rising R. Daily energy expenditure in humans: measurements in a respiratory chamber and by doubly labeled water. In: Kinney JM, Tucker HN, eds. Energy metabolism: tissue determinants and cellular corrolaries. New York: Raven Press, 1991:81-96.
17. Griggs RC, Forbes G, Moxley RT, Evelyn Herr B. The assessment of muscle mass in progressive neuromuscular disease. Neurol 1983;33:158-65.
18. Jozefowicz RF, Welle SL, Nair KS, Kingston WJ, Griggs RC. Basal metabolic rate in myotonic dystrophy: evidence against hypometabolism. Neurology 1987;37:1021-5.
19. Caughey JE, Myrianthopoulos NC. Endocrine function. In: Dystrophia myotonica and related disorders. Springfield, IL: Charles C Thomas, 1963:92-118.
20. Caughey JE, Brown J. Dystrophia myotonica: an endocrine study. Q J Med 1950;19:303-18.
21. Waring JJ, Ravis A, Walker CE. Studies in dystrophia myotonica: clinical features and treatment. Arch Intern Med 1940;65:763-99.
22. Braham J, Sarova-Pinhas I, Czerniak P Radioisotope studies of thyroid function in progressive muscular dystrophy. Isr J Med Sci 1969;5:1188-91.
23. Elia M. Organ and tissue contribution to metabolic rate. In: Kinney JM, Tucker HN, eds. Energy metabolism: tissue determinants and cellular corrolaries. New York: Raven Press, 1991:61-80.
24. Welle S, Jozefowicz R, Forbes G, Griggs RC. Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy. J Clin Endocrinol Metab 1992;74:332-5.
25. Okada K, Manabe S, Sakamoto S, Ohnaka M, Niiyama Y. Protein and energy metabolism in patients with progressive muscular dystrophy. J Nutr Sci Vitaminol (Tokyo) 1992;38:141-54.
26. Dempster P, Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc 1995;27:1692-7.
27. McCrory MA, Gomez TD, Bernauer EM, Mole PA. Evaluation of a new air displacement plethysmograph for measuring human body composition. Med Sci Sports Exerc 1995;27:1686-91.
28. Siri WE. Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Henschel A, eds. Techniques for measuring body composition. Washington, DC: NAS/NRC, 1961:223-4.
29. Lovelady CA, Meredith CN, McCrory MA, Nommsen LA, Joseph LJ, Dewey KG. Energy expenditure in lactating women: a comparison of doubly labeled water and heart-rate-monitoring methods. Am J Clin Nutr 1993:57:512-8.
30. de Weir JBV. New methods for calculating metabolic rate with special reference to protein. J Physiol 1949;109:1-9.
31. Spurr GB, Prentice AM, Murgatroyd PR, Goldberg GR, Reina JC, Christman NT. Energy expenditure from minute-by-minute heart- rate recording: comparison with indirect calorimetry. Am J Clin Nutr 1988;48:552-9.
32. Ainsworth BA, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of the energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
33. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
34. Jéquier E. Energy, obesity, and body weight standards. Am J Clin Nutr 1987;45:1035-6.
35. World Health Organization. Energy and protein requirements. Report of a Joint FAO/WHO/UNU Expert Consultation. World Health Organ Tech Rep Ser 1985;724.
36. Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996;77:64-9.
37. de Groot LCPGM, van Staveren WA. Reduced physical activity and its association with obesity. Nutr Rev 1995;3:11-8.
38. Schoeller DA, Fjeld CR. Human energy metabolism: what have we learned from the doubly labeled water method? Annu Rev Nutr 1991;1:355-73.
39. Saltzman E, Roberts SB. The role of energy expenditure in energy regulation: findings from a decade of research. Nutr Rev 1995;53:209-20.
40. Goldberg GR, Black AE, Jebb SA, et al. Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cutoff limits to identify underrecording. Eur J Clin Nutr 1991;45:569-81.
41. Mertz W, Tsui JC, Judd JT, et al. What are people really eating? The relation between energy intake derived from estimated diet records and intake determined to maintain body weight. Am J Clin Nutr 1991;54:291-5.
42. Danowski TS, Bastiani RM, McWilliams FD, Mater FM, Greenman L. Muscular dystrophy. IV. Endocrine studies. Am J Dis Child 1956;91:356-64.
43. Poehlman ET, Toth MJ. Mathematical ratios lead to spurious conclusions regarding age- and sex-related differences in resting metabolic rate. Am J Clin Nutr 1995;61:482-5.
44. Blahd WH, Lederer M, Cassen B. The significance of decreased body potassium concentrations in patients with muscular dystrophy and nondystrophic relatives. N Engl J Med 1967;276:1349-52.